Zenshine
Latest round
- Series C
Last raised
- Oct 2023
Total raised
- $80M
Investors
- 14
About Zenshine
Founded in 2018 and based in Nanjing, China, Zenshine is a biopharmaceutical company that focuses on the research and development of new small molecule drugs for cancer, viral infection and autoimmune diseases. In 2020, the company's innovative drug ZX-101A was approved by the US FDA for clinical trials. Jinfu Yang, co-founder and chairman of the company, has worked in biotech companies such as Cytokinetics, Proteolix and Calithera as a scientist, deputy director and director. The company has branches in cities such as Beijing and Hangzhou. The company's R&D pipeline includes best-in-class and first-in-class drug molecules. Its main products include ZX-4081, ZX-101A, ZX-7101A and ZX-3000 etc. The company's products are used for diseases such as influenza, tumors, and hematomas. The company generates revenue by doing research, development and providing biopharmaceutical and other related products and services.
Who invested in Zenshine
14 investors across 5 rounds
See all investors in Zenshine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Zenshine
Who invested in Zenshine?
Zenshine has 14 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Zenshine raised?
Zenshine has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Zenshine last raise money?
Zenshine's most recent round on record is a Series C, in Oct 2023.
What does Zenshine do?
Founded in 2018 and based in Nanjing, China, Zenshine is a biopharmaceutical company that focuses on the research and development of new small molecule drugs for cancer, viral infection and autoimmune diseases.
Where is Zenshine headquartered?
Zenshine is headquartered in Nanjing, China.
Which VCs invest in companies like Zenshine?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Zenshine's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Zenshine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.